Prescription drugs that inhibit CYP2D6 activity, which include paroxetine and quinidine, might result in lessened clearance of oxycodone which could lead on to a rise in oxycodone plasma concentrations. Concurrent administration of quinidine resulted in a rise in oxycodone Cmax by 11%, AUC by thirteen%, and t½ elim.Browse the Medication Guideline